Business Standard

Malvinder, Shivinder settlement talk with RFL runs into trouble

Japanese drug major Daiichi Sankyo has been fighting a prolonged legal battle with the Singh brothers

Shivinder Mohan Singh, Malvinder Mohan Singh, Ranbaxy, Fortis, Religare
Premium

File Photo: Former Ranbxy Laboratories promoters Shivinder Mohan Singh (top left) and Malvinder Singh chairman (front centre). Photo: Dalip Kumar

Aashish Aryan New Delhi
The settlement talks between former Fortis Healthcare promoters — brothers Malvinder Mohan Singh and Shivinder Mohan Singh — and Religare Finvest Limited (RFL) were put on hold on Wednesday after Daiichi Sankyo approached the Delhi High Court.

Asking to stop the talks, Daiichi Sankyo, which is pursuing the execution of the Rs 3,500-crore arbitral award, in its plea said the Singh brothers should first settle their claims before offering settlement to any other parties.

In its verbal observation, the Delhi High court on Wednesday morning said the settlement talks between Singh brothers and RFL cannot proceed without seeking permission from it first.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in